Tandem Diabetes Care Inc  

(Public, NASDAQ:TNDM)   Watch this stock  
Find more results for TNDM
-0.03 (-1.20%)
Dec 14 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.45 - 2.75
52 week 2.15 - 30.00
Open 2.70
Vol / Avg. 576,377.00/388,767.00
Mkt cap 24.89M
P/E     -
Div/yield     -
EPS -19.71
Shares 10.12M
Beta 0.17
Inst. own 24%
Mar 6, 2018
Q4 2017 Tandem Diabetes Care Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 29, 2017
Tandem Diabetes Care Inc at Piper Jaffray Healthcare Conference
Nov 14, 2017
Tandem Diabetes Care Inc at Stifel Healthcare Conference
Oct 26, 2017
Q3 2017 Tandem Diabetes Care Inc Earnings Call - Webcast
Oct 26, 2017
Q3 2017 Tandem Diabetes Care Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -59.38% -99.05%
Operating margin -48.76% -92.64%
EBITD margin - -86.12%
Return on average assets -68.96% -70.38%
Return on average equity - -290.04%
Employees 591 -
CDP Score - -


11045 Roselle St Ste 200
SAN DIEGO, CA 92121-1231
United States - Map
+1-858-3666900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Officers and directors

Dick P. Allen Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Kim D. Blickenstaff President, Chief Executive Officer, Director
Age: 64
Bio & Compensation  - Reuters
John Cajigas Chief Financial Officer, Executive Vice President, Treasurer
Age: 51
Bio & Compensation  - Reuters
John F. Sheridan Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
David B. Berger Esq. Executive Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
Brian B. Hansen Chief Commercial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Susan M. Morrison Chief Administrative Officer
Age: 37
Bio & Compensation  - Reuters
Edward L. Cahill Independent Director
Age: 61
Bio & Compensation  - Reuters
Fred E. Cohen Ph.D. M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Howard E. Greene Jr. Independent Director
Age: 74
Bio & Compensation  - Reuters